Related Experiment Video
Updated: Jul 5, 2026

06:38
Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach
Published on: June 11, 2017
Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system
1Division of Neurotoxicology, National Center for Toxicological Research/F3900 NCTR Road, Jefferson, AR 72079-9502, USA. cheng.wang@fda.hhs.gov
Anesthesia and Analgesia
|May 24, 2008
Summary
Anesthetic drugs can cause dose-dependent brain cell death in developing brains. This review explores anesthetic neurotoxicity, focusing on pharmacogenomic approaches to understand and mitigate risks in pediatric patients during critical brain development periods.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Pediatric surgery advances increase anesthesia duration and complexity.
- Anesthetic drugs are known to cause dose-dependent apoptosis in the developing rat brain.
- Nonhuman primates serve as a relevant model for assessing anesthetic neurotoxicity due to physiological similarities to humans.
Purpose of the Study:
- To review anesthetic-induced neuronal cell death during development.
- To describe the application of pharmacogenomic and systems biology approaches for understanding anesthetic neurotoxicity.
- To discuss protection strategies against anesthetic-induced neuronal cell death in pediatric patients.
Main Methods:
- Review of preclinical experimental data, with a focus on ketamine.
- Utilizing nonhuman primate models to assess neurotoxic effects of anesthetics.
- Application of pharmacogenomic and systems biology approaches to study developmental neurotoxicity.
Main Results:
- Anesthetic drugs can induce widespread, dose-dependent apoptosis in the developing brain.
- The window of vulnerability is during rapid synaptogenesis (brain growth spurt period).
- N-methyl-d-aspartate antagonist drugs, as a class, warrant concern regarding neurodegeneration.
Conclusions:
- Further research is needed to address anesthetic-induced brain cell loss, class effects, drug interactions, and human vulnerability periods.
- Pharmacogenomic and systems biology approaches offer valuable tools for understanding anesthetic neurotoxicity.
- Minimizing risks requires a thorough understanding of anesthetic effects on the developing brain.
